Back to Search
Start Over
589 Xevinapant plus nivolumab in patients with advanced solid tumors who progressed on prior anti–PD-1/PD-L1 treatment: results of a dose-optimization, exploratory phase 1b/2 trial
- Source :
- Regular and Young Investigator Award Abstracts.
- Publication Year :
- 2022
- Publisher :
- BMJ Publishing Group Ltd, 2022.
Details
- Database :
- OpenAIRE
- Journal :
- Regular and Young Investigator Award Abstracts
- Accession number :
- edsair.doi...........2028b5fbd64c167f25d424f7354d7b84